Trial record 1 of 2 for:    vs5584
Previous Study | Return to List | Next Study

Phase I Dose Escalation Study of VS-5584 in Subjects With Advanced Non-Hematologic Malignancies or Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01991938
Recruitment Status : Terminated (Lack of recruitment and the company's decision to de-prioritize 5584 development)
First Posted : November 25, 2013
Last Update Posted : January 27, 2017
Information provided by (Responsible Party):
Verastem, Inc.

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : December 2016
  Actual Study Completion Date : December 2016